Hermetica Superfood Encyclopedia
The Short Answer
Euphorbia tirucalli produces a caustic white latex rich in diterpene esters—primarily ingenol and phorbol derivatives—that modulate cutaneous cell signaling through protein kinase C (PKC) activation and exhibit demonstrated antimicrobial and anti-inflammatory activity in preclinical models. In vitro studies document significant antibacterial efficacy against dermatophytes such as Candida albicans and Staphylococcus aureus, and animal studies have shown reduction of inflammatory markers in wound models, though no controlled human clinical trials have established safe or effective topical doses for the Badyara skin-treatment application.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordEuphorbia tirucalli skin benefits
Pencil Cactus — botanical close-up
Health Benefits
**Antimicrobial Activity Against Skin Pathogens**
The latex contains triterpenoids including euphol and tirucallol, as well as diterpene esters, which have demonstrated inhibitory activity against common skin pathogens including Staphylococcus aureus and Candida albicans in disc-diffusion and MIC assays, offering a plausible biochemical basis for traditional wound and skin infection treatments.
**Anti-inflammatory Effects**: Phytosterols and triterpenoids isolated from E
tirucalli stem extracts have suppressed pro-inflammatory cytokine production (TNF-α, IL-6) in macrophage cell-culture models, suggesting a mechanistic basis for the traditional use of diluted preparations in treating inflammatory skin conditions such as eczema-like lesions among the Badyara.
**Wound Healing Support**
Ethanolic stem extracts applied topically in rodent excision-wound models have accelerated wound contraction rates compared to untreated controls, attributed to stimulation of fibroblast proliferation and collagen deposition facilitated by flavonoid and tannin constituents.
**Antifungal Properties for Dermatophytoses**
Latex-derived fractions have demonstrated antifungal efficacy against Trichophyton rubrum and Microsporum gypseum in agar diffusion studies, consistent with traditional Badyara use for ringworm and superficial fungal skin conditions referred to locally as 'makore selu' treatments.
**Potential Antioxidant Defense**
Phenolic acids and flavonoids present in aqueous and methanolic extracts of E. tirucalli exhibit free-radical scavenging activity in DPPH assays, with total phenolic content ranging approximately 15–40 mg GAE/g dry extract, which may contribute to protecting skin cells from oxidative stress in inflammatory dermatoses.
**Antibacterial Action in Oral and Cutaneous Ulcers**
Ethnopharmacological records from West Africa document latex application to oral ulcers and cutaneous sores, and limited in vitro data support inhibitory activity against Streptococcus mutans and Escherichia coli, though the irritant potential of raw latex complicates direct therapeutic extrapolation.
Origin & History
Natural habitat
Euphorbia tirucalli is native to semi-arid tropical and subtropical Africa, with its center of diversity in eastern and southern Africa, including Tanzania, Kenya, and Madagascar, though it has naturalized across West Africa including Senegal. It thrives in dry savanna, rocky hillsides, and degraded soils with minimal rainfall, tolerating drought through its succulent, leafless green stems that photosynthesize in place of foliage. In Senegal, the plant is cultivated near villages and homesteads by the Badyara people, who maintain living hedges both for land demarcation and as a ready source of medicinal latex.
“Euphorbia tirucalli has been used medicinally for centuries across sub-Saharan Africa, with documented use by the Maasai of East Africa for livestock wound treatment, by traditional healers in Zimbabwe for cancer-related pain management, and by communities throughout West Africa for skin conditions, dental pain, and as a fish poison. Among the Badyara people of southern Senegal—a Bainuk-related ethnic group inhabiting the Casamance and Kolda regions—the plant known locally as 'makore selu' occupies a distinct place in ethnodermatological practice, with healers (djambakoulu) applying carefully prepared latex formulations to treat persistent skin ulcers, hyperpigmentation disorders, and suspected fungal infections. The plant's milky white latex has been interpreted symbolically in several African traditions as a purifying or protective fluid, reinforcing its therapeutic prestige beyond its pharmacological properties. Historical Arabic manuscripts and colonial-era botanical surveys from the 19th century document E. tirucalli's widespread medicinal use across the African continent, noting its dual role as a living fence plant and a community pharmacy resource in arid and semi-arid regions.”Traditional Medicine
Scientific Research
The evidence base for Euphorbia tirucalli as a therapeutic agent is largely preclinical and ethnopharmacological, with no published randomized controlled trials in human populations for topical skin applications as of the available literature. In vitro studies published in journals such as the Journal of Ethnopharmacology and African Journal of Pharmacy and Pharmacology have documented antimicrobial and anti-inflammatory properties of latex and stem extracts, with MIC values against S. aureus reported in the range of 0.5–2.0 mg/mL for methanolic fractions. Rodent in vivo models have demonstrated anti-inflammatory effects of euphol-enriched fractions at doses of 10–50 mg/kg body weight, and wound-healing studies in excision models showed approximately 20–35% improvement in wound contraction versus control groups, though these findings have not been replicated in human skin. The most substantial body of research concerns E. tirucalli's anticancer latex constituents in oncology contexts rather than dermatology, and the specific Badyara 'makore selu' preparation has not been subjected to any published controlled study, leaving its clinical efficacy for skin treatment supported only by traditional use documentation and indirect phytochemical plausibility.
Preparation & Dosage
Traditional preparation
**Traditional Badyara Topical Application**
Fresh latex is typically diluted with vegetable oils (such as shea butter or groundnut oil) at ratios reported anecdotally as 1:10 to 1:20 (latex:carrier) before application to affected skin areas; raw undiluted latex is recognized even within traditional practice as capable of causing severe irritation and is not applied directly.
**Decoction of Dried Stems**
5–10 g dry material per 200 mL water) and the cooled liquid is applied as a topical wash, a preparation that substantially reduces phorbol ester concentration compared to raw latex
In some West African traditions, dried and powdered stems are boiled in water (approximately .
**Ethanolic Extract (Research Grade)**
Preclinical studies have used 70–95% ethanolic extracts standardized to euphol content (typically 2–8% euphol by HPLC) at topical concentrations of 1–5% w/v in experimental formulations; no standardized commercial product for skin use has been approved.
**No Established Safe Oral Dose**
Internal ingestion of E. tirucalli latex or extracts is not supported by any clinical safety data and is contraindicated given known acute toxicity at low doses in animal studies; the plant is used externally only in Badyara tradition.
**Timing and Frequency**
Traditional application is typically once to twice daily on affected skin areas for 7–14 days; no clinical trial data exist to validate or refine this regimen.
Nutritional Profile
Euphorbia tirucalli is not consumed as a food source and has no conventional macronutrient or micronutrient nutritional profile of relevance. Its phytochemical composition is dominated by a complex latex fraction containing: diterpene esters (phorbol esters, ingenol esters; estimated 0.1–1.5% dry weight of latex), tetracyclic triterpenoids including euphol and tirucallol (comprising up to 30–40% of latex lipid fraction), beta-sitosterol and other phytosterols (approximately 0.5–2% of ethanolic extract), flavonoids such as kaempferol and quercetin glycosides (5–20 mg/g in aqueous stem extract), tannins (gallic acid equivalents 15–40 mg/g dry extract), and alkaloids in trace quantities. The latex also contains proteolytic enzymes and rubber precursors (cis-polyisoprene). Bioavailability of key terpenoids via topical application is poorly characterized; phorbol esters are known to penetrate the stratum corneum, which underpins both therapeutic potential and irritancy risk.
How It Works
Mechanism of Action
The primary bioactive constituents of Euphorbia tirucalli latex are phorbol ester diterpenes—particularly 12-O-tetradecanoylphorbol-13-acetate (TPA)-like compounds—and ingenol derivatives that act as potent agonists of protein kinase C (PKC) isoforms, modulating downstream NF-κB signaling to exert context-dependent pro- or anti-inflammatory effects depending on concentration and isoform selectivity. Euphol, a tetracyclic triterpene alcohol abundant in the latex, inhibits phospholipase A2 (PLA2) activity, thereby reducing arachidonic acid release and downstream prostaglandin E2 synthesis, which underlies observed anti-inflammatory effects in rodent models at sub-irritant concentrations. The triterpenoid fraction also interacts with toll-like receptor 4 (TLR4) pathways in keratinocytes and macrophages, downregulating MAPK/ERK phosphorylation cascades that drive pro-inflammatory cytokine transcription. Antimicrobial action is attributed to disruption of microbial cell membrane integrity by amphipathic terpenoids and saponins, with secondary contribution from tannins that precipitate bacterial surface proteins and inhibit biofilm formation.
Clinical Evidence
No Phase II or Phase III clinical trials have evaluated Euphorbia tirucalli preparations for dermatological indications in human subjects, which represents a critical gap given the plant's documented traditional use across West and East Africa. The most clinically relevant human-adjacent data derive from a small number of observational ethnopharmacological surveys conducted in Senegal, Tanzania, and Brazil documenting traditional therapeutic applications, but these studies do not measure clinical outcomes, effect sizes, or adverse event rates in a controlled manner. Preclinical rodent and cell-culture data provide biological plausibility for antimicrobial and anti-inflammatory skin benefits but cannot be directly extrapolated to human dosing or efficacy without bridging studies. Overall clinical confidence in efficacy for skin treatments is low, and the known irritant and potentially cocarcinogenic properties of phorbol ester constituents mean that any clinical translation would require rigorous dose-finding and safety trials before recommendation.
Safety & Interactions
Euphorbia tirucalli latex is acutely toxic at low concentrations: direct skin or mucosal contact with undiluted latex causes severe vesicant irritation, chemical burns, and inflammatory reactions due to phorbol ester content, and ocular exposure has caused documented cases of temporary blindness lasting hours to days. Chronic or repeated topical exposure raises concern for co-carcinogenic promotion, as phorbol esters are established tumor promoters in mouse skin models (DMBA/TPA two-stage carcinogenesis protocols), and epidemiological associations between E. tirucalli exposure and Burkitt's lymphoma risk have been hypothesized, though causality in humans is not established. Oral ingestion is contraindicated entirely: animal LD50 data for latex preparations indicate toxicity at doses well within accidental ingestion range, with reported effects including hemorrhagic gastroenteritis, cardiovascular depression, and death in livestock. No formal drug interaction studies exist, but the PKC-activating properties of phorbol esters suggest potential interference with immunosuppressants, retinoid-based topical therapies, and chemotherapeutic agents; use is absolutely contraindicated in pregnancy, lactation, and in individuals with inflammatory skin conditions that compromise barrier function, due to enhanced systemic absorption risk.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Euphorbia tirucalliPencil CactusMilk BushFirestick PlantNaked LadyTirucalli SpurgeMakore selu (Badyara)Mlambu (Swahili)Aveloz (Brazil)
Frequently Asked Questions
Is Euphorbia tirucalli latex safe to apply directly to skin?
Undiluted Euphorbia tirucalli latex is not safe for direct skin application; it contains phorbol ester diterpenes that act as potent vesicants and chemical irritants, causing burns, blistering, and inflammatory reactions on contact. Traditional Badyara healers dilute the latex substantially in carrier oils (ratios of approximately 1:10 to 1:20) before topical use, and even diluted preparations should not be used near the eyes or on broken skin without expert guidance. There are no clinical safety trials establishing a safe topical dose range for any human population.
What are the active compounds in Euphorbia tirucalli that may help skin conditions?
The principal bioactive compounds in E. tirucalli relevant to skin treatment are: phorbol ester diterpenes (PKC modulators with concentration-dependent anti-inflammatory or irritant effects), euphol (a tetracyclic triterpene that inhibits phospholipase A2 and reduces prostaglandin synthesis), tirucallol (a triterpenoid with membrane-active antimicrobial properties), and quercetin/kaempferol flavonoids with antioxidant and anti-inflammatory activity. These compounds act on distinct molecular targets—PKC, PLA2, NF-κB signaling, and microbial membranes—providing a multi-mechanism rationale for traditional dermatological use. However, the same phorbol esters that may confer benefit also carry irritancy and potential co-carcinogenic risk at higher concentrations.
How do the Badyara people of Senegal traditionally prepare makore selu for skin treatment?
The Badyara healers of Senegal's Casamance and Kolda regions collect fresh latex by making incisions in E. tirucalli stems, then carefully blend the white latex with a fatty carrier—most commonly shea butter or groundnut oil—to dilute its irritant potency before application to skin conditions including ulcers, fungal infections, and pigmentation disorders. The preparation is typically applied once or twice daily to affected areas for one to two weeks by the djambakoulu (traditional healer), who selects appropriate dilution ratios based on the condition's severity and the patient's skin sensitivity. This traditional protocol has not been formally documented in peer-reviewed ethnobotanical studies with sufficient methodological detail to permit precise replication.
Can Euphorbia tirucalli cause cancer?
Euphorbia tirucalli is not established as a direct human carcinogen, but its phorbol ester constituents are well-characterized tumor promoters in animal models—they do not initiate cancer but amplify proliferation of already-initiated cells in the classic two-stage DMBA/TPA carcinogenesis model. An epidemiological hypothesis linking E. tirucalli exposure to elevated Burkitt's lymphoma incidence in East Africa has been explored in the literature, with the proposed mechanism involving viral reactivation of Epstein-Barr virus by phorbol esters, though causality in human populations has not been confirmed. Chronic or occupational exposure to raw latex should be avoided on this precautionary basis.
What is the evidence quality for Euphorbia tirucalli as a skin treatment?
The evidence supporting E. tirucalli for skin treatment remains at the preclinical and ethnopharmacological stage, scoring approximately 3 out of 10 on a clinical evidence scale. Available data consist of in vitro antimicrobial and anti-inflammatory assays, limited rodent wound-healing studies showing roughly 20–35% improved wound contraction, and observational ethnobotanical surveys—with no published randomized controlled trials in human subjects for any dermatological indication. Until human safety and efficacy trials are conducted, the use of E. tirucalli preparations for skin conditions should be approached with significant caution, particularly given the well-documented irritant and potential co-carcinogenic properties of its latex.
Does Euphorbia tirucalli latex interact with topical antibiotics or antifungal medications?
While Euphorbia tirucalli contains compounds with antimicrobial activity against pathogens like Staphylococcus aureus and Candida albicans, there are no documented clinical studies examining potential interactions with conventional topical antibiotics or antifungals. Concurrent use with prescription topical treatments should only occur under medical supervision due to the latex's potency and potential for skin irritation. Limited research means interactions cannot be ruled out, particularly regarding absorption or competing mechanisms of action.
Who should avoid using Euphorbia tirucalli due to safety concerns?
Pregnant women, nursing mothers, and young children should avoid Euphorbia tirucalli due to insufficient safety data and the plant's known toxicity potential. Individuals with sensitive skin, eczema, psoriasis, or open wounds may experience severe irritation, as the latex's irritant diterpene esters can cause dermatitis in susceptible populations. People with a history of allergic reactions to Euphorbia species should also avoid this ingredient entirely.
What is the difference between fresh Euphorbia tirucalli latex and dried or processed forms for skin applications?
Fresh latex from Euphorbia tirucalli contains higher concentrations of volatile and unstable compounds, including irritant diterpene esters, whereas dried or processed forms may have reduced potency and altered antimicrobial efficacy depending on preparation methods. Traditional preparations by the Badyara people involve specific processing techniques that likely stabilize beneficial triterpenoids like euphol and tirucallol while minimizing unwanted irritation. The bioavailability and safety profile differ significantly between raw and processed forms, making preparation method critical for both efficacy and tolerability.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w makore-selu-euphorbia-tirucalli curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
